Biktarvy is an antiviral medicine used to treat adults and children from 2 years of age and weighing at least 14 kg infected with human immunodeficiency virus 1 (HIV-1), a virus that causes acquired immune deficiency syndrome (AIDS). Biktarvy contains the active substances bictegravir, emtricitabine and tenofovir alafenamide. It is only used in patients where the virus has not developed resistance to a class of HIV medicines called integrase inhibitors or to tenofovir or emtricitabine.
Therapeutic Indication
### Therapeutic indication Biktarvy is indicated for the treatment of human immunodeficiency virus 1 (HIV 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir.(see section 5.1)
Therapeutic Area (MeSH)
ATC Code
J05AR20
ATC Item
emtricitabine, tenofovir alafenamide and bictegravir
Pharmacotherapeutic Group
Antivirals for systemic use
Active Substance (Summary)
INN / Common Names
EMA Name
Biktarvy
Medicine Name
Biktarvy
Aliases
N/A
